C07AB14 • landiolol • Cardiovascular system | Beta blocking agents | Beta blocking agents, selective
Landiolol is a medication used to control supraventricular tachycardia and perioperative hypertension. It is an ultra-selective beta-blocker with rapid action that reduces heart rate and blood pressure by blocking beta-1 adrenergic receptors.
The medication is administered intravenously, usually in a hospital setting, under the supervision of a doctor. Due to its rapid onset and short duration of effect, it is ideal for use in acute situations.
Side effects may include low blood pressure, bradycardia, dizziness, or nausea. In rare cases, severe allergic reactions or heart failure may occur.
Patients should inform their doctor about any other medications they are taking and be closely monitored during treatment. Pregnant or breastfeeding women should consult a specialist before use.
Substance: landiolol
Date of last drug list: 01-03-2017
Commercial code: W63184001
Concentration: 600mg
Pharmaceutical form: powder infusion solution
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).